Brogan, Shane E <br/><br/>
A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.  [electronic resource] 

 -  Pain medicine (Malden, Mass.)  Apr 2013 
 - 478-86 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1526-4637 
<br/><br/><label>Standard No.: </label>10.1111/pme.12060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analgesia, Patient-Controlled--economics<br/>Analgesics, Opioid--administration & dosage<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Drug Utilization--economics<br/>Emergency Medical Services--economics<br/>Emergency Service, Hospital--economics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infusion Pumps, Implantable--economics<br/>Injections, Spinal<br/>Male<br/>Middle Aged<br/>Neoplasms--complications<br/>Pain Measurement<br/>Pain, Intractable--drug therapy<br/>Patient Admission--economics<br/>Retrospective Studies<br/>Survival<br/>Treatment Outcome